Chinese patent medicine helps with recovery from COVID

The Chinese patent medicine Bufei Huoxue capsule (BFHX) has significant rehabilitative effects on physiological activity in patients recovering from COVID-19, and can attenuate symptoms of fatigue and improve exercise tolerance. BFHX contains three Chinese herbs, Huang Qi (Radix Astragali), Chi Shao (Radix Paeoniae Rubra) and Bu Gu Zhi (Fructus Psoraliae). A total of 131 patients convalescing from COVID-19 were randomly divided into a BFHX group and a placebo group. BFHX or placebo was given orally three times a day (1.4g per dose) for 90 days. After three months of treatment, the BFHX group exhibited greater attenuation of pneumonia lesions on chest CT than the placebo group (15.09% versus 7.84%). Six patients in the placebo group developed worsening of pneumonia, whereas none in the BFHX group exhibited deterioration. Improvements in six-minute walk distance relative to baseline were also significantly better in the BFHX group than in the placebo group, as were fatigue scores.

Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial. J Ethnopharmacol. 2022 Feb 10;284:114830.